BCM
ANAC

Bridgeway Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bridgeway Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-40,650
Closed -$721K – 1578
2014
Q2 		$721K Sell
40,650
-12,500
-24% -$201K 0.02% 920
2014
Q1 		$1.06M Sell
53,150
-64,650
-55% -$1.25M 0.03% 733
2013
Q4 		$1.98M Sell
117,800
-85,300
-42% -$1.18M 0.06% 481
2013
Q3 		$2.16M Buy
203,100
+17,800
+10% +$156K 0.07% 392
2013
Q2 		$1.04M Buy
+185,300
New +$1.12M 0.04% 615

Other funds holding ANAC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridgeway Capital Management's ANAC Position: Q3 2014 in Review

Bridgeway Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2014, closing a stake of 40,650 shares — an estimated $721K sold.

Bridgeway Capital Management first reported a position in ANAC in Q2 2013 and held it in 5 quarters. The position peaked at $2.16M in Q3 2013. 116 funds tracked by Wall St. Rank hold ANAC as of Q3 2014.

  • Bridgeway Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 40,650 ANACOR PHARMACEUTICALS INC COM shares in Q3 2014, an estimated $721K.
  • Bridgeway Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 5 quarters.
  • Bridgeway Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $2.16M in Q3 2013.
  • 116 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2014.

Based on Bridgeway Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.